Bill Snyder Archive — Page 53 of 121

Three study leaders stand together in a laboratory, with workbenches, equipment, and a microscope visible around them. From left to right: Greg Poffenberger, Chunhua Dai, and John Walker.
February 20, 2020

Post-transplant diabetes may be reversible: study

Post-transplantation diabetes mellitus (PTDM), a common complication of immunosuppressive drugs that are given to prevent transplant rejection, may be reversible and at least partially preventable, researchers at VUMC report.

Five people pose in front of a gray wall; the two men second and third from left hold circular awards. The group is identified in the caption as Larry Marnett, Alan Simmons, Sean Schaffer, Kristina Williams, and Jennifer Pietenpol.
February 19, 2020

Awards honor research staff’s crucial contributions

Laboratory and administrative personnel at VUMC were honored last week for research excellence during the 16th annual Research Staff Awards luncheon.

White pills scattered on a surface beside an overturned amber prescription bottle with more pills spilling from its opening.
February 19, 2020

Vanderbilt University Medical Center among top 100 proposals for MacArthur Foundation $100 million grant

The John D. and Catherine T. MacArthur Foundation today unveiled a grant proposal from Vanderbilt University Medical Center (VUMC) as one of the highest-scoring proposals, designated as the “Top 100,” in its 100&Change competition for a single $100 million grant to help solve one of the world’s most critical societal challenges.

Networked dots in the shape of a brain
February 13, 2020

Algorithm helps improve coronary calcium detection

A new algorithm for artificial intelligence-assisted calcium scoring can accurately determine cardiovascular risk across a range of CT scans and in a racially diverse population.

Dark, thin, curved line forming a stylized abstract shape with two loops on a textured blue background.
February 6, 2020

Antibody mixture may help block Ebola virus infection

A research team led by scientists at Vanderbilt University Medical Center has developed an antibody mixture that in animals is highly effective in blocking infection by the Ebola virus.

Portrait of Jeff Conn wearing a light blue collared shirt against a plain light background.
February 6, 2020

Conn, Calipari to receive major pharmacology awards

Two Vanderbilt University pharmacologists have won prestigious awards from the American Society for Pharmacology and Experimental Therapeutics (ASPET).